ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 16.0 | 20.4 | 18.1 |
| Other income | 0.1 | 0.7 | 0.2 |
| Total income | 16.0 | 21.1 | 18.3 |
| Profit before exceptional items & tax | 0.4 | 1.7 | 1.5 |
| Profit before tax | 0.4 | 1.7 | 1.5 |
| Net profit | 0.3 | 1.2 | 1.0 |
| Operating margin | 2.5% | 8.1% | 8.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -70.00% |
|---|---|
| Net profit, quarter on quarter | -75.00% |
| Revenue, year on year | -11.60% |
| Operating profit, year on year | -75.00% |
| Operating profit, quarter on quarter | -60.00% |
BSE results filing, NSE: MERCURYLAB. Figures extracted from the filing.
Mercury Laboratories Ltd: key numbers
- Share price
- ₹765.00
- Market cap
- ₹91.80 Cr
- Revenue (annual)
- ₹75.94 Cr
- Net profit (annual)
- ₹4.83 Cr
- P/E (TTM)
- 28.7×Sector 43.8×
- Promoter holding
- 73.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mercury Laboratories Ltd
All →Mercury Laboratories Q2 FY27 Results: Net Profit ₹0.7 Cr, Down 56.2% YoY
Mercury Laboratories Ltd reported unaudited financial results for the quarter ended September 30, 2026. The company recorded a net profit of ₹0.67 Crore.
- Key figure
- Net profit ₹0.7 Cr · -56.2% YoY
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Mercury Laboratories Management Change
Mercury Laboratories disclosed the cessation of Manager-HR Jaydeepsinh Raj, effective October 28, 2026. The employee stopped reporting for duty without prior intimation to the company.
Mercury Laboratories Other Announcement
Mercury Laboratories Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b). The report provides a standard breakdown of the company's current equity ownership structure.
Mercury Laboratories Management Change
Mr. Dilip Ramanlal Shah has ceased to be a Non-Executive Director of Mercury Laboratories Limited following the non-approval of his re-appointment at the recent AGM.
Mercury Laboratories Annual General Meeting
Mercury Laboratories Limited conducted its 45th Annual General Meeting on September 28, 2026. Shareholders considered agenda items including financial statements adoption and a ₹3.50 per share dividend.